Vousden Karen H — SEC Form 4 filings

SEC reporting owner CIK 1723884. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-05 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BRISTOL MYERS SQUIBB CO (BMY)Director33
Faeth Therapeutics, Inc. (FTH)Director11

Form 4 filings — Vousden Karen H

FiledFormIssuerReported transactionsSource
2026-09-154Faeth Therapeutics, Inc. (FTH)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2026-02-034BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,996.37 (derivative) @ $55.05EDGAR
2025-02-044BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 3,562.34 (derivative) @ $58.95EDGAR
2024-02-054BRISTOL MYERS SQUIBB CO (BMY)Grant/award (A): 4,314.77 (derivative) @ $48.67EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1723884 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →